Ann Parker Cardiology Pharmacist Frimley Health

Slides:



Advertisements
Similar presentations
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 8 Cardiovascular.
Advertisements

Antiarrhythmic Agents: Cardiac Stimulants and Depressants
ARRHYTHMIAS TACHYCARDIA>100/min BRADYCARDIA
Or Doing Drugs for Your Heartbeat
Aims Introduction to the heart.
Drugs for Dysrhythmias 19. Learning Outcomes 1. Explain how rhythm abnormalities can affect cardiac function. 2. Illustrate the flow of electrical impulses.
Pharmacology I Drugs Used to Treat Arrhythmias. Arrhythmias Needing Treatment: Atrial Fibrillation/Flutter (AF) Supraventricular Tachycardia (SVT) Ventricular.
Cardiac Arrhythmias.
Atrial Fibrillation Steve McGlynn
Prepared by : Nehad J. Ahmed.  Heart failure, also known as congestive heart failure (CHF), means your heart can't pump enough blood to meet your body's.
Co-ordination of the Cardiac Cycle Aims Describe how heart action is coordinated with reference to the sinoatrial node (SAN), the atrioventricular node.
Arrhythmia recognition and treatment
Arrhythmia Tasha McDevitt Patient Care Sciences II Inst: Dr. Hoeff.
Edit the text with your own short phrases. The animation is already done for you; just copy and paste the slide into your existing presentation. To change.
Drugs for CCF Heart failure is the progressive inability of the heart to supply adequate blood flow to vital organs. It is classically accompanied by significant.
Your heart is a muscle that works continuously like a pump Each beat of your heart is set in motion by an electrical signal from within your heart muscle.
Advanced Cardiac Care in the Streets Understanding EKGs Ray Taylor Valencia Community College Electrophysiology.
ANTIARRHYTHMIC DRUGS Department of Pharmacology and Toxicology
© Assoc. Prof. Ivan Lambev
Section 3, Lecture 4 Antiarrhytmic drugs cont…
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. 1 CHAPTER 23 Antiarrhythmic Drugs.
Atrial Fibrillation Dr Nidhi Bhargava 8/10/13.
Antidysrhythmic Drugs
Atrial Fibrillation Andreas Stein Robert Smith, M.D. August 11, 2003.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 23 Antidysrhythmic Drugs.
CARDIOVASCULAR SYSTEM PHYSIOLOGY. Pulmonary circulation: Path of blood from right ventricle through the lungs and back to the heart. Systemic circulation:
Chapter 17 Cardiac Stimulants and Depressants. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved
Chapter Goals After studying this chapter, students should be able to describe the general functions of the major components of the heart. 2. describe.
Lecture Objectives Describe sinus arrhythmias Describe the main pathophysiological causes of cardiac arrhythmias Explain the mechanism of cardiac block.
Medical Progress: Heart Failure. Primary Targets of Treatment in Heart Failure. Treatment options for patients with heart failure affect the pathophysiological.
Co-ordination of the Cardiac Cycle SBI3U. The heart is made of cardiac muscle. When the cells receive an electrical impulse they contract - causing a.
BIMM118 Cardiac Arrhythmia Arrhythmias : Abnormal rhythms of the heart that cause the heart to pump less effectively Arrhythmia occurs: –when the heart’s.
Causes of cardiac arrhythmias
Section 3 Lecture 3 Antiarrhythmic Drugs Heart beats (HB) originate from AV node Normal 70 beats/min at rest Arrhythmia (dysrhythmia): Abnormal.
Heart Failure. Background to Congestive Heart Failure Normal cardiac output needed to adequately perfuse peripheral organs – Provide O 2, nutrients, etc.
23 Antiarrhythmic Drugs.
SIGNS AND SYMPTOMS 1-Chest pain 2-Dyspnea 3-Palpitation 4-Syncopal attach.
Arrhythmias. Cardiac dysrhythmia Cardiac dysrhythmia (arrhytmia) Abnormal electrical activity in the heart.
ANTI-ARRHYTHMIC DRUGS
Copyright © 2006 Pearson Education, Inc., publishing as Benjamin Cummings Differences in Contraction Mechanisms  Heart has autorhythmicity (approx. 1%)
Heart Failure What is Heart Failure? The heart is not pumping properly.  Usually, the heart has been weakened by an underlying condition  Blocked arteries.
Heart Failure: medication Types of Heart Failure Systolic (or squeezing) heart failure –Decreased pumping function of the heart, which results in fluid.
Arrhythmia Arrhythmias are abnormal beats of the heart.
Conduction System GR 12 B. The Conduction System A. The cardiac muscle is autorhythmic, meaning it can contract without nerve impulses or hormones. B.
Pharmacology PHL 101 Abdelkader Ashour, Ph.D. 10 th Lecture.
Palpitations & Atrial Fibrillation Dr Mehul B Dhinoja, Consultant Cardiologist & Electrophysiologist BMI The London Independent Hospital.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 33 Disorders of Cardiac Conduction and Rhythm.
ARRHYTHMIAS Jamil Mayet. Arrhythmias - learning objectives –Mechanisms of action of antiarrhythmic drugs –Diagnosis To differentiate the different types.
BY MRUNMAYI JOGLEKAR NAMRATA KAUL
Cardiovascular Cardiovascular pharmacology pharmacology.
Heart Failure  Dfinition:  Clinical features  Underlying causes of HF include Arteriosclerotic heart disease, MI, hypertensive heart disease, valvular.
Copyright © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 25 Disorders of Cardiac Conduction and Rhythm.
Cardiac Rhythm.
Conduction Disturbances: Cardiac Arrhythmias and Heart Block
Antidysrhythmic Agents
Cardiac action potential
Cardiovascular System Block Cardiac Arrhythmias (Physiology)
AF in 2014 Dr Stewart Healy.
©2012 Lippincott Williams & Wilkins. All rights reserved.
Drug Therapy Heart Failure
Lesson starter Name the four heart chambers
Atrial fibrillation (AF) and flutter
The Cardiovascular System
Bradycardias and atrioventricular conduction block
ANTI HYPERTENSIVE DRUGS
Antiarrhythmic drugs [,æntiə'riðmik] 抗心律失常药
CARDIOVASCULAR AGENTS
Chapter 30 Antiarrhythmic Drugs
Antiarrhythmic Drugs Types of Cardiac Arrhythmias:
Arrhythmias Simple-dysfunction cause abnormalities in impulse formation and conduction in the myocardium. However, in clinic it present as a complex family.
Presentation transcript:

Ann Parker Cardiology Pharmacist Frimley Health Cardiac Medication Ann Parker Cardiology Pharmacist Frimley Health

Aims Overview of: Anti-arrhythmic medication Anticoagulation in AF Medication in heart failure And an opportunity for you to ask questions

Electrical conduction system of the heart Inherent rate – rate at which cells spontaneously initiate impulses. Atria 60-100 beats/min. AV node 40-60 beats. Vetricles 20-40 beats. Depolarisation ( the movement of charged ions across a cell membrane ) results in myocardial contraction. At resting state K+ in the cell and Na+ and Ca+ outside When an electrical impulse spreads through the muscle from the SA node the Na+ pump channels open and the K+ closes, electrolytes change place across the cell membrane

Arrhythmia When the electrical impulses that coordinate heartbeats are not working properly, making the heart beat too fast/slow or inconsistently. Many heart arrhythmias are harmless. Some may cause troublesome and even potentially fatal symptoms. We all occasionally experience irregular heartbeats, which may feel like a racing heart or fluttering.

Digoxin Works by inhibiting the sodium- potassium pump Helps to control heart rate, particularly in the irregular atrial fibrillation Increases cardiac contractility Medical use first described in 1785

Vaughan -Williams Classification Class I - sodium channel blockers eg Disopyramide, Flecainide, Mexilitine Class II- Betablockers Class III- potassium channel blockers eg Amiodarone Class IV- calcium channel blockers eg Verapamil, Diltiazem

Sodium channel blockers eg mexilitene, flecainide slows conduction in the heart makes the heart tissue less sensitive (reduce ventricular response) Side effects -dizziness, heartburn, nausea, nervousness, trembling, unsteadiness usually reversible and dose-related.

Betablockers Reduce the effect of adrenaline on the heart (sympathetic nervous system blockade) Slow the heart by depressing sinus node function and AV node conduction Can help maintain sinus rhythm Protective of the heart as reduce oxygen demand depression of sinus node (natural pacemaker) function and atrioventricular node (electrical relay station between the upper and lower chambers of the heart conduction

Potassium channel blockers eg amiodarone increases the refractory period via sodium and potassium channel effects has beta blocker like and calcium channel blocker like actions on the SA and AV node slows intra-cardiac conduction These electrophysiologic effects are reflected in a decreased sinus rate of 15 to 20%, increased PR and QT intervals of about 10%, the development of U-waves, and changes in T-wave contour. These changes should not require discontinuation of Amiodarone as they are evidence of its pharmacological action, although Amiodarone can cause marked sinus bradycardia or sinus arrest and heart block. On rare occasions, QT prolongation has been associated with worsening of arrhythmia

Act in the AV node to prolong conduction time and refractory period

Anticoagulation in AF, why? Risk of stroke assesses usings CHADsVASc score

Congestive heart failure CHADS2VASc Risk Factor Score Congestive heart failure 1 Hypertension Age >75years 2 Diabetes Stroke Vascular disease Age 65-74 years Sex category (female)

HASBLED Hypertension Abnormal renal and liver function Stroke Bleeding Labile INRs Elderly Drugs or alcohol

Anticoagulation Warfarin NOACs (or DOACs) eg. apixaban, dabigatran, rivaroxaban

Warfarin affects the body’s ability to synthesise vitamin K which is used in production of factors 2, 7, 9 and 10.

Heart failure treatment Type – LVSD of HFPEF Angiotensin converting enzyme inhibitors (ACEI) Betablockers Aldosterone antagonists Angiotensin receptor neprilysin inhibitor (ARNI) Natriuretic peptides (NPs) are a family of hormones that help maintain sodium and fluid balance. Natriuretic peptides (NPs) are a family of hormones that help maintain sodium and fluid balance.

References https://www.pinterest.com/pin/404338872771327665/ https://www.studyblue.com/notes/note/n/antiarrhythmic-drugs/deck/775590 https://uk.pinterest.com/pin/329536897715737090/ http://en.wikipedia.org/wiki/File:ConductionsystemoftheheartwithouttheHeart.png http://pmj.bmj.com/content/90/1067/520.abstract http://www.medicines.org.uk/emc/medicine/25742 https://www.pinterest.com/pin/404338872771546154/